Key result
Tirzepatide linked to reduced risk of initial ischemic stroke in adults with T2D.
Why the study?
Does tirzepatide prevent initial ischemic stroke in adults with type 2 diabetes mellitus?
Does tirzepatide prevent initial ischemic stroke in adults with type 2 diabetes mellitus?
This target trial emulation aims to assess the potential role of tirzepatide on primary stroke prevention in patients with type 2 diabetes mellitus.
Answers are grounded in this paper and cite their sources.
Does not yet support changing stroke prevention in type 2 diabetes; leaves open confirmation in dedicated trials.
To assess the potential role of tirzepatide on primary stroke prevention in patients with type 2 diabetes mellitus (T2DM).
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question. Tirzepatide was associated with a reduced risk of initial ischemic stroke in adults with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: